Hepion Pharmaceuticals, Inc. (HEPA) DCF Valuation

Hepion Pharmaceuticals, Inc. (HEPA) Valoración de DCF

US | Healthcare | Biotechnology | NASDAQ
Hepion Pharmaceuticals, Inc. (HEPA) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Hepion Pharmaceuticals, Inc. (HEPA) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

¿Busca evaluar el valor intrínseco de Hepion Pharmaceuticals, Inc.? Nuestra calculadora DCF (HEPA) integra datos del mundo real con extensas funciones de personalización, lo que le permite optimizar sus pronósticos y mejorar sus opciones de inversión.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -7.7 -20.1 -30.3 -43.5 -49.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .0 .1 .1 .1 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -7.8 -20.1 -30.4 -43.6 -49.3 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 13.9 40.7 91.3 51.2 14.8 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .5 3.7 2.4 2.7 2.3 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.1 -.1 -.1 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0.82907 0.82907 0.82907 0.82907 0.82907 0.82907 0.82907 0.82907 0.82907 0.82907
EBITAT -6.9 -20.2 -30.4 -40.8 -48.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -6.4 -17.0 -31.7 -40.5 -49.2 -2.3 .0 .0 .0 .0
WACC, % 12.08 12.14 12.14 12.11 12.13 12.12 12.12 12.12 12.12 12.12
PV UFCF
SUM PV UFCF -2.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -15
Equity Value 12
Diluted Shares Outstanding, MM 4
Equity Value Per Share 3.14

What You Will Get

  • Comprehensive HEPA Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Real-Time Calculations: Intrinsic value and NPV are calculated automatically and in real-time.
  • Scenario Analysis: Explore various scenarios to assess Hepion Pharmaceuticals' future performance.
  • User-Friendly Interface: Designed for industry professionals while remaining easy to navigate for newcomers.

Key Features

  • Customizable Clinical Parameters: Adjust essential metrics such as trial success rates, market potential, and R&D expenditures.
  • Instant DCF Valuation: Provides immediate calculations for intrinsic value, NPV, and additional financial metrics.
  • High-Precision Analysis: Leverages Hepion’s actual financial data for accurate valuation results.
  • Effortless Scenario Testing: Evaluate various assumptions and analyze outcomes with ease.
  • Efficiency Booster: Remove the hassle of constructing intricate valuation models from the ground up.

How It Works

  • Step 1: Download the prebuilt Excel template with Hepion Pharmaceuticals' (HEPA) data included.
  • Step 2: Explore the pre-filled sheets and familiarize yourself with the key metrics.
  • Step 3: Update forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly view recalculated results, including Hepion Pharmaceuticals' intrinsic value.
  • Step 5: Make informed investment decisions or generate reports using the outputs.

Why Choose This Calculator for Hepion Pharmaceuticals, Inc. (HEPA)?

  • All-in-One Solution: Features DCF, WACC, and comprehensive financial ratio analyses tailored for Hepion Pharmaceuticals.
  • Flexible Parameters: Modify yellow-highlighted cells to explore different investment scenarios for (HEPA).
  • In-Depth Analysis: Automatically computes Hepion’s intrinsic value and Net Present Value for informed decision-making.
  • Preloaded Information: Historical and projected data provide reliable starting points for analysis.
  • Expert Level: Perfect for financial analysts, investors, and consultants focusing on the biotechnology sector.

Who Should Use This Product?

  • Pharmaceutical Students: Understand drug development processes and apply theoretical knowledge using real-world data.
  • Researchers: Integrate advanced models into your studies or clinical trials.
  • Investors: Evaluate your investment strategies and assess valuation outcomes for Hepion Pharmaceuticals, Inc. (HEPA).
  • Market Analysts: Enhance your analysis with a ready-to-use, customizable financial model.
  • Healthcare Entrepreneurs: Discover how large biotech firms like Hepion are evaluated in the market.

What the Template Contains

  • Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Hepion Pharmaceuticals, Inc. (HEPA).
  • Real-World Data: Hepion's historical and projected financials preloaded for in-depth analysis.
  • Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
  • Key Ratios: Integrated analysis for profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results specific to Hepion Pharmaceuticals, Inc. (HEPA).

No products were found matching.